Effect of Blood Flow Restriction Aerobic Training on Body Composition, Cardiorespiratory Performance and Quality of Life in Young Obese Females
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- Body Mass Index
Study Overview
Brief Summary
This study investigates the effects of Blood Flow Restriction (BFR) Aerobic Training on various parameters in young obese females. It explores changes in body composition, cardiorespiratory performance, and quality of life resulting from this novel exercise approach. Through controlled interventions, the research aims to elucidate the potential benefits of BFR training in improving health outcomes among this demographic. By analyzing data on body composition shifts, cardiovascular endurance enhancements, and subjective assessments of well-being, the study aims to provide insights into the efficacy of BFR aerobic training as a potential strategy for managing obesity-related health concerns in young females.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Masking
- Participant and Investigator Blinded
Eligibility Criteria
- Ages
- 18.00 Year(s) to 25.00 Year(s) (—)
- Sex
- Female
Inclusion Criteria
- •BMI Grade I between 30-34.9 kg/m2 Prior to the commencement of the study, none of the participants had engaged in regular strength, resistance, and/or aerobic exercise.
Exclusion Criteria
- •Body mass index – more than Grade I Any recent Musculoskeletal injury of the lower limb Peripheral vascular disorders Any Metabolic disorder Bone and joint disease.
- •Anyone already undergoing aerobic & Resistance training Neuropsychological disorders Recent Myocardial infarction.
Outcomes
Primary Outcomes
Body Mass Index
Time Frame: Baseline and 12 weeks
Muscle strength and endurance by Dynamometer
Time Frame: Baseline and 12 weeks
Heart Rate, BP, Vo2 Max by PFT(FVC,FEV1 and ratio)
Time Frame: Baseline and 12 weeks
SPo2
Time Frame: Baseline and 12 weeks
Blood Glucose and lactic Acid Profile
Time Frame: Baseline and 12 weeks
Secondary Outcomes
- WHOQOL- BRIEF(Baseline, 6 months and 12 months)
Investigators
Sumera Khan
Galgotias University